Home Cart Sign in  
Chemical Structure| 1341-23-7 Chemical Structure| 1341-23-7

Structure of Nicotinamide riboside
CAS No.: 1341-23-7

Chemical Structure| 1341-23-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Nicotinamide riboside increases NAD[+] levels and activates SIRT1 and SIRT3, culminating in enhanced oxidative metabolism and protection against high fat diet-induced metabolic abnormalities.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Nicotinamide riboside

CAS No. :1341-23-7
Formula : C11H15N2O5
M.W : 255.25
SMILES Code : O[C@H]1[C@H]([N+]2=CC=CC(C(N)=O)=C2)O[C@H](CO)[C@H]1O
MDL No. :MFCD16621007
InChI Key :JLEBZPBDRKPWTD-TURQNECASA-O
Pubchem ID :439924

Safety of Nicotinamide riboside

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Nicotinamide riboside

epigenetics

Isoform Comparison

Biological Activity

Description
Nicotinamide riboside, a precursor of NAD+ that is effective when taken orally, boosts NAD+ levels and stimulates the activity of SIRT1 and SIRT3. It acts as a form of vitamin B3 (niacin) and promotes oxidative metabolism, offering protection from metabolic issues induced by a high-fat diet[1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06534944 Peripheral Artery Disease PHASE1|PHASE2 ACTIVE_NOT_RECRUITING 2024-12-30 University of Oklahoma Health ... More >>Sciences Center, Oklahoma City, Oklahoma, 73104, United States Less <<
NCT06324877 Ataxia Telangiectasia NOT_YET_RECRUITING 2025-10-30 Queensland Children's Hospital... More >>, Brisbane, Queensland, 4101, Australia Less <<
NCT04430517 Mild Cognitive Impairment|Mild... More >> Alzheimer Disease Less << EARLY_PHASE1 RECRUITING 2025-04-30 McLean Hospital, Belmont, Mass... More >>achusetts, 02478, United States Less <<
NCT04040959 Vascular Diseases|Kidney Disea... More >>se|Blood Pressure|Oxidative Stress Less << PHASE2 RECRUITING 2024-09-15 UColorado, Aurora, Colorado, 8... More >>0045, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.92mL

0.78mL

0.39mL

19.59mL

3.92mL

1.96mL

39.18mL

7.84mL

3.92mL

References

 

Historical Records

Categories